Call me maybe? The right time and place for BPAs in EHRs.
作者信息
Steinberg Benjamin A, Piccini Jonathan P
机构信息
Division of Cardiovascular Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
Duke Clinical Research Institute, Durham, NC, USA.
出版信息
Eur Heart J. 2020 Mar 7;41(10):1097-1099. doi: 10.1093/eurheartj/ehz526.
Abstract
摘要
相似文献
1
Call me maybe? The right time and place for BPAs in EHRs.或许联系我？电子健康记录中双酚A的合适时机与地点。
Eur Heart J. 2020 Mar 7;41(10):1097-1099. doi: 10.1093/eurheartj/ehz526.
3
[Non valvular atrial fibrillation: the place of the new anticoagulants].[非瓣膜性心房颤动：新型抗凝剂的地位]
Rev Med Brux. 2015 Sep;36(4):365-72.
4
Evidence-Based Anticoagulation Decision Making for Atrial Fibrillation--How We Are Doing? (Maybe Not So Well?).基于证据的心房颤动抗凝决策制定——我们做得如何？（可能不太好？）
Can J Cardiol. 2016 Mar;32(3):278-80. doi: 10.1016/j.cjca.2015.06.025. Epub 2015 Oct 15.
5
Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action.非维生素K口服抗凝剂用于“瓣膜性”心房颤动：行动呼吁
Europace. 2016 Jan;18(1):1-3. doi: 10.1093/europace/euv318. Epub 2015 Oct 12.
6
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.非维生素K拮抗剂口服抗凝药时代之前心房颤动患者的抗栓治疗：心房颤动患者长期口服抗栓治疗全球注册研究（GLORIA-AF）第一阶段队列研究
Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073. Epub 2016 Jun 21.
8
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation.将依度沙班纳入房颤抗凝药物选择。
Thromb Haemost. 2016 Jan;115(2):257-70. doi: 10.1160/TH15-02-0181. Epub 2015 Oct 15.
9
A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation.呼吁对术后房颤患者进行口服抗凝治疗的随机试验。
J Am Coll Cardiol. 2019 Mar 12;73(9):1105. doi: 10.1016/j.jacc.2018.11.057.
10
Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.心房颤动消融术前后口服抗凝药的使用：关于围手术期心房颤动消融术预防血栓栓塞的个体口服抗凝药使用的当前证据综述
J Cardiovasc Electrophysiol. 2014 Dec;25(12):1411-8. doi: 10.1111/jce.12546. Epub 2014 Oct 10.
本文引用的文献
1
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).针对未接受抗凝治疗的高危住院房颤患者的基于警报的计算机化决策支持：一项随机对照试验（AF-ALERT）
Eur Heart J. 2020 Mar 7;41(10):1086-1096. doi: 10.1093/eurheartj/ehz385.
2
Assessment of Inpatient Time Allocation Among First-Year Internal Medicine Residents Using Time-Motion Observations.运用时间动作观察评估第一年内科住院医师的住院时间分配。
JAMA Intern Med. 2019 Jun 1;179(6):760-767. doi: 10.1001/jamainternmed.2019.0095.
3
Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research.利用社会安全管理局死亡主档案评估临床研究中的死亡率数据。
JAMA Cardiol. 2019 Apr 1;4(4):375-379. doi: 10.1001/jamacardio.2019.0198.
4
Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization.心力衰竭住院期间的起始、持续、转换和停药。
JACC Heart Fail. 2019 Jan;7(1):1-12. doi: 10.1016/j.jchf.2018.06.011. Epub 2018 Nov 7.
5
SUPPORT-AF: Piloting a Multi-Faceted, Electronic Medical Record-Based Intervention to Improve Prescription of Anticoagulation.SUPPORT-AF：试点多方面、基于电子病历的干预措施以改善抗凝药物处方
J Am Heart Assoc. 2018 Sep 4;7(17):e009946. doi: 10.1161/JAHA.118.009946.
6
Effectiveness of CHADS-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.基于 CHADS-VASc 的决策支持对房颤卒中预防的有效性：一项普通实践中的聚类随机试验。
Int J Cardiol. 2018 Dec 15;273:123-129. doi: 10.1016/j.ijcard.2018.08.096. Epub 2018 Sep 8.
7
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.心房颤动患者临床特征及口服抗凝治疗的国际趋势：来自GARFIELD-AF、ORBIT-AF I和ORBIT-AF II注册研究的结果。
Am Heart J. 2017 Dec;194:132-140. doi: 10.1016/j.ahj.2017.08.011. Epub 2017 Aug 24.
8
Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral-Anticoagulation-Naïve Patients With Atrial Fibrillation: A Randomized Trial.用于改善住院的初治口服抗凝剂心房颤动患者卒中预防的电子警报系统：一项随机试验
J Am Heart Assoc. 2016 Jul 22;5(7):e003776. doi: 10.1161/JAHA.116.003776.
9
Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.老年房颤患者抗凝治疗的禁忌证及新型抗凝剂的适用情况
Cardiovasc Ther. 2015 Aug;33(4):177-83. doi: 10.1111/1755-5922.12129.
10
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.医生在心房颤动中关于口服抗凝禁忌的实践：来自 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation（ORBIT-AF）登记研究的结果。
Am Heart J. 2014 Apr;167(4):601-609.e1. doi: 10.1016/j.ahj.2013.12.014. Epub 2014 Jan 4.
Zotero 插件